 RALEIGH, NC ACCESSWIRE May 5, 2022 9 Meters Biopharma, Inc. NASDAQ:NMTR, a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced today that John Temperato, President Chief Executive Officer of 9 Meters, will present at the LifeSci Partners Immunology Inflammation Symposium on May 10, 2022, and the H.C. Wainwright Global Investment Conference to be held on May 23-26, 2022. 